AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.
about
The central role of hypothalamic inflammation in the acute illness response and cachexiaAssociation of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric CancerPhospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer.New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
P2860
AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@ast
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@en
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@nl
type
label
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@ast
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@en
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@nl
prefLabel
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@ast
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@en
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@nl
P2093
P2860
P50
P1433
P1476
AKT1 and SELP polymorphisms pr ...... in pancreatic cancer patients.
@en
P2093
Andrea Mambrini
Godefridus J Peters
Majid Ghayour-Mobarhan
Maurizio Cantore
Mina Maftouh
Paola Pacetti
Tessa Y S Le Large
P2860
P304
P356
10.1371/JOURNAL.PONE.0108057
P407
P577
2014-09-19T00:00:00Z